Human HepG2 Hepatocellular Carcinoma Expansion Media

Cellular Engineering Technologies

Catalog No.: CET-MR1010

HepG2 Human Hepatocellular Carcinoma Expansion Media

HepG2 Human Hepatocellular Carcinoma Expansion Media is a high-performance culture medium specifically formulated to support the robust expansion and metabolic activity of HepG2 hepatocellular carcinoma cells [i]. This media provides essential nutrients, growth factors, and buffering agents to maintain optimal pH and cellular homeostasis, ensuring high cell viability and proliferation rates.

HepG2 cells play a crucial role in liver function research, cancer metastasis studies, and toxicity screening by actively secreting major plasma proteins, including albumin, α2-macroglobulin, α1-anti-trypsin, and plasminogen. HepG2 Media is an excellent choice for drug metabolism studies, liver toxicity assays, and cancer biology research.

Product Features:

• Optimized for HepG2 cell expansion CET-CR1015-500 – Supports high-density culture and metabolic stability.
• Compatible with serum supplementation – Designed for use with customer-preferred animal-origin serum.
• Enhanced cell attachment and growth – Promotes uniform monolayer formation while sustaining hepatic functionality.
• Ideal for liver toxicity and cancer research – Supports HepG2 cells in various in vitro applications, including carcinogenesis studies and drug screening.

Recommended Uses for HepG2 Expansion Media:

• Expansion and maintenance of HepG2 hepatocellular carcinoma cells CET-CR1015-500
• Drug metabolism and hepatotoxicity screening
• Liver disease modeling and regenerative medicine research

Shipping & Storage:

• Shipped with gel packs to maintain stability during transport.
• Storage recommendation: Store at 2–8°C and protect from light to maintain optimal media performance.

Citations for Human HepG2 Hepatocellular Carcinoma Expansion Media – 4 Found

Minami, Tatsuro; Satoh, Kimio; Nogi, Masamichi; Kudo, Shun; Miyata, Satoshi; Tanaka, Shin-ichi; Shimokawa, Hiroaki. Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells. Cardiovascular Research. 2016;109(1):151-61. 

Yasuoka, Hidetaka; Asai, Akira; Ohama, Hideko; Tsuchimoto, Yusuke; Fukunishi, Shinya; Higuchi, Kazuhide. Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis. Scientific Reports. 2020;10(1):10377. 

Tani, Naoto; Ikeda, Tomoya; Ishikawa, Takaki. Relationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepines. Human & Experimental Toxicology. 2023;42:9603271231171643. 

Tani, Naoto; Ikeda, Tomoya; Ishikawa, Takaki. Effect of methamphetamine on clock genes and drug-metabolizing enzyme expression. Human & Experimental Toxicology. 2022;41:9603271221124092.